KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Income from Continuing Operations (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Income from Continuing Operations for 13 consecutive years, with 111432000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 57.67% to 111432000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 352081000.0 through Dec 2025, down 47.12% year-over-year, with the annual reading at 352081000.0 for FY2025, 47.12% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 111432000.0 at Xenon Pharmaceuticals, down from 90896000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 129748000.0 in Q4 2023, with the low at 111432000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 34113400.0, with a median of 44594000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations crashed 12533.71% in 2021, then surged 428.18% in 2022.
  • Over 5 years, Income from Continuing Operations stood at 25564000.0 in 2021, then soared by 428.18% to 83896000.0 in 2022, then soared by 54.65% to 129748000.0 in 2023, then tumbled by 154.47% to 70676000.0 in 2024, then plummeted by 57.67% to 111432000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 111432000.0, 90896000.0, and 84706000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.